Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

HiFiBiO Therapeutics Signs Multi-Target Antibody Discovery Agreement with Takeda

Tuesday, July 31, 2018

HiFiBiO Therapeutics a world leader in the discovery of therapeutic antibodies through singleBcell screening and analysis today announced a multitarget agreement with Takeda Pharmaceutical Company Limited Takeda to enable the discovery of breakthroug...

Kymab Announces Promising Results from Initial Clinical Study of New Antibody KY1005 for Treatment of Autoimmune Diseases

Monday, July 30, 2018

Kymab a clinicalstage biopharmaceutical company developing fully human monoclonal antibody therapeutics announces today that it has obtained positive data in its Phase I trial of KY and will proceed to Phase II studies in atopic dermatitis with addit...

KEYTRUDA® (pembrolizumab) is the First Anti-PD-1 Therapy Approved in China for Advanced Melanoma

Friday, July 27, 2018

Merck known as MSD outside the United States and Canada today announced that KEYTRUDA Mercks antiPD therapy has been approved by the China National Drug Administration CNDA for the treatment of adult patients with unresectable or metastatic melanoma...

Genprex Enters Agreement with the University of Texas MD Anderson Cancer Center to Study Oncoprex in Combination with Immunotherapies

Friday, July 27, 2018

Genprex Inc a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform has entered a Sponsored Research Agreement Agreement with The University of Texas MD Anderson Cancer Cen...

Innovent Receives IND Approval to Initiate Clinical Trials in China with its anti-OX40 Agonistic Antibody IBI101 and its anti-RANKL Antibody IBI307

Thursday, July 26, 2018

Innovent Biologics a worldclass Chinabased biopharmaceutical company that develops and intends to commercialize high quality innovative antibodybased therapeutics today announced that it has received Investigational New Drug IND approval from the Chi...

MEDISCA Announces Exclusive Partnership with German Manufacturer SAMIX

Thursday, July 26, 2018

MEDISCA a global leader in the pharmaceutical compounding industry and SAMIX a premium compounding systems manufacturer announced today the launch of SAMIX Systems a new line of highly reliable and versatile compounding systems for efficient mixing T...

AbbVie Receives U.S. FDA Approval of ORILISSA™ (elagolix) for the Management of Moderate to Severe Pain Associated with Endometriosis

Wednesday, July 25, 2018

AbbVie a researchbased global biopharmaceutical company in cooperation with Neurocrine Biosciences Inc announced that the US Food and Drug Administration FDA approved ORILISSA elagolix the first and only oral gonadotropinreleasing hormone GnRH antag...

Bristol-Myers Squibb and Tsinghua University Announce Collaboration to Accelerate Early Research into Potential Therapies for Autoimmune Diseases and Cancer

Wednesday, July 25, 2018

BristolMyers Squibb Company and Tsinghua University have entered into a collaboration to discover therapeutic agents against novel targets for autoimmune diseases and cancers The collaboration brings together BristolMyers Squibb and Tsinghua Universi...

Cambrex to Acquire Halo Pharma, Adding Drug Development and Finished Dosage Capabilities to Global API Manufacturing Network

Tuesday, July 24, 2018

Cambrex Corporation a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients APIs today announced it has entered into a definitive agreement to acquire Halo Pharma Halo a leading dosage form Contract Developmen...

Adamis Pharmaceuticals Adds Sublingual Erectile Dysfunction Product Candidate to its Pipeline

Tuesday, July 24, 2018

Adamis Pharmaceuticals Corporation announced today that it has been conducting preIND development work for a fastdissolving sublingual tablet containing tadalafil Adamis intends to submit an investigational new drug IND application to the US Food and...